National Institute for Pharmaceutical Development

The National Institute for Pharmaceutical Development (NIPD), officially Guangzhou National Institute for Pharmaceutical Development Co., Ltd., is a comprehensive pharmaceutical research and development enterprise based in Guangzhou, China. Operating as a key subsidiary of Guangzhou Pharmaceutical Holdings Limited (GPHL), the institute provides integrated CRO and CDMO services, including drug discovery, preclinical safety assessment, and formulation development. NIPD is particularly recognized for its expertise in the modernization of Traditional Chinese Medicine (TCM) and the development of innovative chemical entities. The organization manages several state-level research platforms and maintains a pipeline of internal candidates while supporting the R&D needs of the broader GPHL group and external partners. The institute serves as a critical bridge between laboratory research and commercial manufacturing for the Chinese healthcare sector.